Heart Failure: Is There an Ideal Biomarker?

Area of Science:

• Cardiology
• Biomarker Research
• Public Health

Background:

• Heart failure (HF) prevalence is rising globally, posing a significant public health challenge.
• Understanding HF's pathophysiological mechanisms is crucial for effective management.
• Biomarkers have become integral to managing patients with acute and chronic HF.

Purpose of the Study:

• To review the role of established and emerging biomarkers in HF.
• To explore how biomarkers inform treatment, prognosis, and patient follow-up.
• To highlight the impact of biomarkers on managing HF comorbidities.

Main Methods:

• Literature review of existing research on HF biomarkers.
• Analysis of pathophysiological mechanisms linked to HF.
• Evaluation of biomarker utility in clinical HF management.

Main Results:

• Biomarker research has elucidated underlying pathophysiological mechanisms in HF.
• Established and novel biomarkers aid in treatment guidance and prognostic assessment.
• Integrated biomarker strategies show promise in risk stratification and reducing rehospitalizations.

Conclusions:

• Biomarkers are essential tools for optimizing HF therapy and patient follow-up.
• An integrated biomarker approach improves mortality prediction and reduces healthcare costs.
• Further research into emerging biomarkers will enhance HF patient care.